Skip to main content

Summit Global Investments

Position in NVS — Novartis AG

CIK 1697953 BOUNTIFUL, UT

Position in NVS

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$441,166
+$26,297 QoQ
Shares Held
2,815
+3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#948
of 1,603 holders
Holding Since
Mar 2020
22 quarters on record

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Summit Global Investments holds $32,800,954 across 11 Drug Manufacturers - General names. NVS ranks #11 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $441,166 2,815
2026-03-31 $414,869 2,716
2025-12-31 $369,905 2,683
2025-06-30 $709,844 5,866
2025-03-31 $1,462,729 13,121
2024-12-31 $3,518,145 36,154
2023-12-31 $2,410,456 23,873
2023-09-30 $3,626,114 35,599
2023-06-30 $3,192,691 31,639
2023-03-31 $2,801,676 30,453
2022-12-31 $2,746,094 30,270
2022-09-30 $2,161,344 28,435
2022-06-30 $1,424,245 16,849
2022-03-31 $1,543,083 17,585
2021-12-31 $1,542,008 17,629
2021-09-30 $1,437,119 17,573
2021-06-30 $1,173,528 12,862
2021-03-31 $1,155,091 13,513
2020-12-31 $1,150,346 12,182
2020-09-30 $847,164 9,742
2020-06-30 $783,876 8,975
2020-03-31 $597,185 7,243